Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) Change in Receivables (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of Change in Receivables data on record, last reported at $159000.0 in Q4 2019.

  • For Q4 2019, Change in Receivables rose 160.46% year-over-year to $159000.0; the TTM value through Dec 2019 reached $43000.0, down 93.86%, while the annual FY2024 figure was -$133000.0, 146.34% down from the prior year.
  • Change in Receivables reached $159000.0 in Q4 2019 per DMAC's latest filing, up from -$448000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $721000.0 in Q3 2018 and bottomed at -$467000.0 in Q2 2018.